Flinton Capital Management’s bluebird bio BLUE Stock Holding History

Flinton Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-271	Closed	-$512K	–	870
2018 Q3	$512K	Sell	271 -95	-26%	-$196K	0.02%	490
2018 Q2	$743K	Sell	366 -54	-13%	-$123K	0.02%	359
2018 Q1	$929K	Sell	420 -123	-23%	-$313K	0.03%	288
2017 Q4	$1.25M	Sell	543 -87	-14%	-$177K	0.04%	251
2017 Q3	$1.12M	Sell	630 -33	-5%	-$46.1K	0.04%	255
2017 Q2	$903K	Buy	663 +37	+6%	+$44.6K	0.03%	283
2017 Q1	$737K	Hold	626	–	–	0.03%	306
2016 Q4	$501K	Buy	+626	New	+$497K	0.02%	329

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flinton Capital Management's BLUE Position: Q4 2018 in Review

Flinton Capital Management sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 271 shares — an estimated $512K sold.

Flinton Capital Management first reported a position in BLUE in Q4 2016 and held it in 8 quarters. The position peaked at $1.25M in Q4 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

Flinton Capital Management reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
Flinton Capital Management sold 271 bluebird bio shares in Q4 2018, an estimated $512K.
Flinton Capital Management first reported a position in bluebird bio in Q4 2016 and held it in 8 quarters.
Flinton Capital Management's bluebird bio position peaked at $1.25M in Q4 2017.
251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Flinton Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.